TIFFANY THOMAS: Open Payments
NPI 1083180319 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 29 payments from 9 companies in 2025. Trend: 2023 $889 · 2024 $431 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $255 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Vifor Pharma, Inc. | 3 | $69 |
| Fresenius USA Marketing, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: KRYSTEXXA, JYNARQUE, Veltassa, VELPHORO, JARDIANCE, FARXIGA, TARPEYO.
Industry payments across AL — which companies pay providers there.
